Rare Incidence of Ventricular Tachycardia and Torsades de Pointes in Hospitalized Patients With Prolonged QT Who Later Received Levofloxacin: A Retrospective Study
- 1 May 2015
- journal article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 90 (5) , 606-612
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Cardiovascular Risks with Azithromycin and Other Antibacterial DrugsNew England Journal of Medicine, 2013
- Institution-Wide QT Alert System Identifies Patients With a High Risk of MortalityMayo Clinic Proceedings, 2013
- Fluoroquinolones and the Risk of Serious Arrhythmia: A Population-Based StudyClinical Infectious Diseases, 2012
- QT Prolongation and Torsade de Pointes Induced by Fluoroquinolones: Infrequent Side Effects from Commonly Used MedicationsCardiology, 2011
- Effects of fluoroquinolones on HERG channels and on pancreatic β-cell ATP-sensitive K+ channelsToxicology, 2006
- QTc Prolongation Associated with Combination Therapy of Levofloxacin, Imipramine, and FluoxetineAnnals of Pharmacotherapy, 2005
- Torsades de pointes associated with fluoroquinolones: Importance of concomitant risk factorsClinical Pharmacology & Therapeutics, 2004
- Clinical Relevance and Management of Drug‐Related QT Interval ProlongationPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2003
- Levofloxacin Induced Polymorphic Ventricular Tachycardia with Normal QT IntervalPacing and Clinical Electrophysiology, 2001
- Effects of fluoroquinolones on HERG currentsEuropean Journal of Pharmacology, 2000